CCL20 and myeloid sarcoma: The CCL20-CCR6 axis exemplifies this mechanism, where intestinal epithelial-derived CCL20 guides ILC3s across compromised BBB regions into the CNS, where the production of neuroprotective IL-22 by the ILC3a mitigates demyelination in MS models (142, 143).